Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BMX 010

Next Previous
Search
Drug Profile

BMX 010

Alternative Names: BMX 010; MnTE-2-PyP

Latest Information Update: 06 May 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Duke University
  • Developer BioMimetix
  • Class Anti-inflammatories; Antiacnes; Antipruritics; Antipsoriatics; Metalloporphyrins; Skin disorder therapies; Small molecules
  • Mechanism of Action NF-E2-related factor 2 stimulants; NF-kappa B inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Atopic dermatitis; Plaque psoriasis; Pruritus; Rosacea
  • Discontinued Acne vulgaris

Most Recent Events

  • 15 Apr 2024 BioMimetix terminates a phase II trial for Atopic dermatitis in USA (Topical) due to funding constraints (NCT05491447)
  • 08 Nov 2022 BioMimetix initiates a phase II trial for Atopic dermatitis in USA (Topical, Ointment) (NCT05491447)
  • 28 Sep 2022 BioMimetix suspended a phase-II clinical trial in Rosacea in USA (Topical, Cream) (NCT03756389)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top